Skip to main content

Table 2 Odds ratios for muscle-invasive bladder cancer at diagnosis comparing antidepressant users to non-users

From: Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

 

Complete case analysis

2011–2015

Muscle-invasive (pT2+)

Non-muscle-invasive (pT1)

Unadjusted

odds ratio (95% CI)

Adjusteda

odds ratio (95% CI)

 

Unadjusted

odds ratio (95% CI)

Adjusteda

odds ratio

(95% CI)

n

%

n

%

Non-users (n = 7392)

3854

52.1

3538

47.9

Ref.

Ref.

Non-users (n = 3938)

Ref.

Ref.

AD users (n = 860)

437

50.8

423

49.2

0.95

(0.82–1.09)

0.86

(0.74–0.99)

AD users (n = 490)

0.96

(0.79–1.16)

0.87

(0.71–1.05)

  1. Results of complete case analysis (2005–2015) and when restricting the analysis to 2011 through 2015. AD antidepressant, CI confidence interval. aAdjusted for age, sex, CCI, alcohol-related disorders, and marital status